An open-labelled, Prospective, three arm, single center, randomized clinical study to compare patient satisfaction and clinical outcome associated with available nasal packs in nasal surgery

Dr Akhil Pratap Singh Trial Investigator0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年6月24日

试验速览

暂无简介。

•1. Subject eligible for the use of a nasal pack (either VELNEZ, Merocel or Rapid Rhino) in routine clinical practice after a planned nasal surgery.
•2. Male and female in the age group of 18 to 70 years. (Both Included)
•3. Subjects who can provide informed consent form in writing.
•4. Subjects who allow their study data to be collected at pre-defined follow-up period.

•1. Subject who are unable to be treated with the other than VELNEZ, Merocel or Rapid Rhino nasal pack in routine clinical practice after a planned nasal surgery.
•2. Subject unwilling or unable to comply with the postoperative visits necessary for data collection.
•3. Subject with an active infection at the surgery site.
•4. Subject with a history of asthma.
•5. Subject who are on aspirin or anti-platelet drugs therapy.
•6. Hypertensive subjects.
•7. Subjects who have a history of allergy (Hypersensitive) reactions with any of the ingredients of the nasal pack.
•8. Subject with bleeding disorders.
•9. Any medical condition that, in the opinion of the investigator, would make the subject unsuitable for inclusion (e.g., a chronic, relapsing or hereditary disease that may interfere with the outcome of the study)

发起方

Dr Akhil Pratap Singh Trial Investigator